Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,334.50
Bid: 1,335.00
Ask: 1,336.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.075%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,334.50
PSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capital Markets Event

17 Apr 2018 08:30

RNS Number : 1370L
Persimmon PLC
17 April 2018
 

17 April 2018

Persimmon plc

Capital Markets Event and Update on Manufacturing Initiatives - 7th and 8th November 2018

Persimmon plc ("the Company") is pleased to announce that it will hold a Capital Markets Event on the evening of Wednesday 7 November and during Thursday 8 November 2018.

The senior management team of Persimmon will host the event at the Company's off-site manufacturing hub at Harworth, Doncaster. Attendees will be invited to tour the Company's new brick manufacturing plant and to review the progress being made in establishing the new roof tile manufacturing facility. An update will also be provided on the progress of the Company's Space4 business, which produces timber frames, highly insulated wall panels and roof cassettes to deliver a 'fabric first' approach to the construction of new homes. The Company continues to expand the output of the Space4 business in support of the Group's further growth.

Jeff Fairburn, CEO said "We believe our Harworth manufacturing hub is a major differentiator for Persimmon and is already making a substantial contribution to our brick volumes, an area where the industry is currently facing supply constraints. We expect the facility to play an increasingly significant role in the supply of building materials to our business as we continue to increase our new home construction volumes."

In addition, the Capital Markets Event will provide attendees with the opportunity to gain a further insight into the following additional matters relating to the Persimmon Group:

·

 

On site productivity

 

·

Planning - the application of Government planning policy guidelines in the light of recent policy adjustments

 

·

Strategic land - Persimmon's opportunities in the near, and longer, term

 

·

The Cycle - performance, and how the Company's strategy mitigates the risks to sustaining higher levels of shareholder value creation posed by the inherent cyclicality of the UK housing market

 

Invitations will be distributed shortly.

A short trading update will be released on 7 November 2018.

The Company recently announced record results for 2017 based on excellent operational performance, delivering a 24% increase in operating profit from average capital employed which was 5% lower, year on year. Over the last six years since the launch of its new strategy in 2012, the Company has increased its annual output of new homes by over 70%, generated £2.8 billion of free cash before return of surplus capital to shareholders whilst investing £3.2 billion in new land. Over this period the Company's performance has delivered total shareholder returns of c. 470%, which places the Company third in the FTSE 100 Index.

Enquiries:

 

Citigate Dewe Rogerson

Tel: +44 (0) 20 7638 9571

 

 

Simon Rigby

 

Kevin Smith

 

Jos Bieneman

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDDLBFVZFFBBQ
Date   Source Headline
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company
8th Nov 20237:00 amRNSAppointment of Chief Financial Officer
7th Nov 20237:00 amRNSQ3 Trading Statement
3rd Nov 20231:15 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
10th Aug 20237:04 amRNSHalf Year Results
27th Jul 202310:13 amRNSDirectorate Change
10th Jul 20239:27 amRNSDirector Declaration
3rd Jul 20232:46 pmRNSTotal Voting Rights
1st Jun 20234:38 pmRNSTR-1: Notification of major holdings
1st Jun 20231:07 pmRNSBlock listing Interim Review
1st Jun 202311:06 amRNSTotal Voting Rights
3rd May 20235:00 pmRNSHolding(s) in Company
3rd May 20234:12 pmRNSDirector/PDMR Shareholding
2nd May 202311:13 amRNSTotal Voting Rights
26th Apr 20234:32 pmRNSResult of AGM
26th Apr 20237:00 amRNSQ1 Trading Statement
3rd Apr 20234:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:05 pmRNSTotal Voting Rights
27th Mar 20233:44 pmRNSDirector/PDMR Shareholding
22nd Mar 20233:00 pmRNSAnnual Report 2022 and Notice of AGM 2023
13th Mar 20231:57 pmRNSDirectorate Change
13th Mar 202312:19 pmRNSUK Government Self Remediation Contract Signed
7th Mar 20235:33 pmRNSHolding(s) in Company
7th Mar 20237:04 amRNSDirector Declaration
6th Mar 20235:02 pmRNSHolding(s) in Company
1st Mar 20237:00 amRNSFull Year Results
12th Jan 20237:00 amRNSTrading Statement
1st Dec 20225:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20225:25 pmRNSVoting Rights and Capital
8th Nov 20227:00 amRNSTrading Statement
1st Nov 20221:00 pmRNSTotal Voting Rights
1st Nov 20229:24 amRNSHolding(s) in Company
10th Oct 20222:24 pmRNSDirector/PDMR Shareholding
5th Oct 202210:26 amRNSHolding(s) in Company
4th Oct 20223:07 pmRNSDirector/PDMR Shareholding
3rd Oct 20222:12 pmRNSTotal Voting Rights
22nd Sep 20223:54 pmRNSDirector/PDMR Shareholding
17th Aug 20227:00 amRNSHalf Year Results
1st Aug 20222:30 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.